✦ LIBER ✦

PCN10 MALIGNANT GASTROINTESTINAL STROMAL TUMORS TREATED WITH IMATINIB IN FRANCE: EFFICACY IN REAL LIFE

✍ Scribed by JY Blay; O Bouché; M Cucherat; M Goldberg; P Grosclaude; R Sambuc; S Bisot-Locard; C Deschaseaux; J Sailly

Book ID: 118611855
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 91 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)74262-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN15 CHRONIC MYELOID LEUKEMIA TREATED W

PCN15 CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB IN FRANCE: EFFICACY IN REAL LIFE

✍ F Guilhot; J Reiffers; P Rousselot; F Sigaux; M Cucherat; M Goldberg; P Grosclau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

9415 Malignant gastrointestinal stromal

9415 Malignant gastrointestinal stromal tumours treated with imatinib in France: results in unselected patients

✍ Bouché, O.; Cioffi, A.; Rios, M.; Blesius, A.; Chaigneau, L.; Ray-Coquard, I.; B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Correlation of immunophenotype with prog

Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate

✍ Lucian R. Chirieac; Jonathan C. Trent; Dejka M. Steinert; Haesun Choi; Ying Yang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

Is there a role for surgery in patients

Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

✍ Courtney L Scaife; Kelly K Hunt; Shreyaskumar R Patel; Robert S Benjamin; Michae 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Expression of Bcl-2 in gastrointestinal

Expression of Bcl-2 in gastrointestinal stromal tumors : Correlation with progression-free survival in 81 patients treated with imatinib mesylate

✍ Dejka M. Steinert; Mauricio Oyarzo; Xuemei Wang; Haesun Choi; Peter F. Thall; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract ## BACKGROUND The natural history of gastrointestinal stromal tumor (GIST) has been revolutionized by imatinib mesylate (imatinib) therapy. Before imatinib, Bcl‐2 expression in GIST was associated with a worse prognosis or added no additional prognostic value. To the authors' knowledge

Efficacy and safety profile of imatinib

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

✍ Toshirou Nishida; Kuniaki Shirao; Akira Sawaki; Masato Koseki; Takeshi Okamura; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 258 KB